EASi-KIDNEY international trial reaches 1,000 participants! Find out more!

🎉 #EASiKIDNEY hits 1,000 participants to date!

100+ investigators. 20 countries.

We’re building strong evidence for future chronic kidney disease treatments—a condition affecting 1 in 10 globally.
Congratulations to Hospital Tuanku Ampuan Najihah for recruiting the 1000th 👉 buff.ly/NPRaFnw

#EASIKIDNEY is an international randomised trial aiming to recruit 11,000 patients living with #chronickidneydisease, demonstrating #powerincollaboration to find treatments for the 1 in 10 people living with #CKD worldwide.

Find out more 👉 buff.ly/Fx63Qrz

#CTD2025

Happy Clinical Trials Day!

Today we are celebrating three of our clinical trials: #ASCENDPLUS, #EASIKIDNEY, and #RECOVERY. Find out more about how each of these trials is leveraging public engagement and collaboration to improve human health👇

#CTD2025 #powerinpurpose